EP 0912551 A1 19990506 - SOMATOSTATIN AGONISTS AND ANTAGONISTS
Title (en)
SOMATOSTATIN AGONISTS AND ANTAGONISTS
Title (de)
SOMATOSTATIN-AGONISTEN UND -ANTAGONISTEN
Title (fr)
AGONISTES ET ANTAGONISTES DE LA SOMATOSTATINE
Publication
Application
Priority
- DK 9700222 W 19970514
- DK 57696 A 19960514
Abstract (en)
[origin: WO9743278A1] The present invention relates to somatostatin ligands (Ia) or (Ib) which are useful for treating medical disorders related to binding to human somatostatin receptor subtypes, wherein X is =S, =O, =NH, =NCOPh or =N(CN), A is aryl optionally substituted with halogen, amino, hydroxy, nitro, C1-6-alkyl, C1-6-alkoxy or aryl, B is aryl optionally substituted with halogen, amino, hydroxy, C1-6-alkyl, C1-6-alkoxy or aryl, D is aryl, amino, optionally substituted with halogen, amino, hydroxy, C1-6-alkyl, C1-6-alkoxy or aryl, or a pharmaceutically acceptable salt thereof.
IPC 1-7
IPC 8 full level
A61K 31/44 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/47 (2006.01); A61K 31/4709 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61P 1/04 (2006.01); A61P 5/02 (2006.01); A61P 9/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 213/74 (2006.01); C07D 213/75 (2006.01); C07D 215/38 (2006.01); C07D 401/12 (2006.01)
CPC (source: EP)
A61K 31/4439 (2013.01); A61K 31/4709 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61P 1/04 (2017.12); A61P 5/02 (2017.12); A61P 9/00 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07D 213/74 (2013.01); C07D 401/12 (2013.01)
Citation (search report)
See references of WO 9743278A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9743278 A1 19971120; AU 2764797 A 19971205; EP 0912551 A1 19990506; JP 2001525793 A 20011211; ZA 974147 B 19971114
DOCDB simple family (application)
DK 9700222 W 19970514; AU 2764797 A 19970514; EP 97921646 A 19970514; JP 54040897 A 19970514; ZA 974147 A 19970514